# Patricio Duarte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patricio-duarte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 540 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 7 |
| i10-index | 7 |
| Last Known Institution | Universidad Hospital Italiano |
| OpenAlex ID | https://openalex.org/A5009263584 |
| ORCID iD | 0009-0007-3715-7115 |
| Works | 52 |

## Researcher papers

- [Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency](https://scholariq.org/papers/intravenous-iron-reduces-nt-pro-brain-natriuretic-peptide-in-anemic-patients/)
- [Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study](https://scholariq.org/papers/different-outcomes-for-transplant-eligible-newly-diagnosed-multiple-myeloma/)
- [Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study](https://scholariq.org/papers/treatment-and-survival-outcomes-of-waldenstrom-macroglobulinemia-in-latin/)
- [Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score](https://scholariq.org/papers/predicting-mortality-after-autologous-transplant-development-of-a-novel-risk/)
- [Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America](https://scholariq.org/papers/patients-age-40-years-and-younger-with-multiple-myeloma-have-the-same-prognosis/)
- [\[Spontaneous spleen rupture associated to active cytomegalovirus infection\].](https://scholariq.org/papers/spontaneous-spleen-rupture-associated-to-active-cytomegalovirus-infection/)
- [Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple](https://scholariq.org/papers/real-world-outcomes-with-scp-bortezomib-thalidomide-dexamethasone-scp-and-scp/)
- [Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors](https://scholariq.org/papers/haploidentical-transplant-in-adult-patients-with-acute-lymphoblastic-leukemia-in/)
- [Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group](https://scholariq.org/papers/primary-plasma-cell-leukemia-in-latin-america-demographic-clinical-and/)
- [Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>](https://scholariq.org/papers/real-world-outcomes-for-the-treatment-of-relapsed-refractory-multiple-myeloma/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Researcher university

- [Universidad Hospital Italiano](https://scholariq.org/institutions/universidad-hospital-italiano/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.